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Abstract
Background: Analysis of the pathogen interactome is a powerful approach for dissecting potential
signal transduction and virulence pathways. It also offers opportunities for exploring new drug
targets.
Results: In this study, a protein-protein interaction (PPI) network of Mycobacterium tuberculosis
H37Rv was constructed using a homogenous protein mapping method, which has shown molecular
chaperones, ribosomal proteins and ABC transporters to be highly interconnected proteins. A
further analysis of this network unraveled the function of hypothetical proteins as well as a potential
signaling pathway. A hypothetical protein, Rv2752c, which was linked to a metal cation-transporting
ATPase, was characterized as a metal-beta-lactamase, through domain analysis in combination with
an in vitro activity experiment. A second hypothetical protein, Rv1354c, and an unknown protein
kinase, PknK, interacted with a similar group of inner membrane-associated ABC transporters in
the PPI network. The interactions of Rv1354 with these proteins were also confirmed by a further
bacterial two-hybrid analysis. According to protein domain structures, the unique M. tuberculosis
Rv1354c gene was proposed, for the first time, to be responsible for the turnover of cyclic-di-GMP,
a second messenger molecule in this bacterium. A further structure-based inhibitors screening for
Rv1354c was also performed in silicon.
Conclusion:  We constructed a comprehensive protein-protein interaction network for M.
tuberculosis consisting of 738 proteins and 5639 interaction pairs. Our analysis unraveled the
function of hypothetical proteins as well as a potential signaling pathway. The group of ABC
transporters, PknK, and Rv1354c were proposed to constitute a potential membrane-associated
signaling pathway that cooperatively responds to environmental stresses in M. tuberculosis. The
study therefore provides valuable clues in exploring new signaling proteins, virulence pathways, and
drug targets.
Background
The intracellular pathogen Mycobacterium tuberculosis, the
causative agent of tuberculosis (TB), is responsible for
nearly two million human deaths worldwide every year.
In addition, one-third of the world's population is cur-
rently infected with the TB bacillus. The situation has
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worsened in recent years with the emergence of multi-
drug resistant TB and co-infection with HIV [1]. Under-
standing the signal transduction behind virulence and the
infection mechanisms of M. tuberculosis is therefore criti-
cal for the identification of new drug targets and the devel-
opment of new drugs.
The M. tuberculosis bacterium confronts a highly hostile
environment during infection, including restricted access
to nutrients and reduced oxygen tension [2]. Its ability to
infect under these conditions has been suggested that it
may use unique pathogenic mechanisms to facilitate inte-
grated responses to the multiple stresses it encounters
within the phagosome. However, little is known regarding
the specific bacterial components involved in this process.
Moreover, the molecular mechanism involved in sensing
of extracellular signals for inducing its metabolic adapta-
tion still remains unclear.
Protein-protein interactions (PPI) play significant roles in
many biological processes, such as in the assembly of
molecular complexes or in signal transduction. At a more
applied level, protein interaction networks also provide
tools for exploration of novel drug targets [3]. However,
characterization of large-scale protein interaction net-
works from most organisms is still problematic due to the
expense and lengthy time requirements of these types of
studies. However, interaction data based on a high
throughput experimental technique from model organ-
isms can be utilized in cases where orthologs of interact-
ing proteins can be clearly identified [4]. Walhout et al. [5]
introduced the notion of the 'interolog', orthologous pairs
of interacting proteins in different organisms. This idea
was further extended to include paralogous interactions
[6]. Orthologous interactions, or protein pairs with inter-
acting orthologs, have been used to construct entire inter-
actomes for organisms for which actual experimental
interactions are sparse [7-9].
In this study, we constructed an M. tuberculosis PPI net-
work consisting of 738 proteins and 5639 interaction
pairs using a homogenous protein mapping method.
Analysis of this network has provided a number of valua-
ble clues for exploration of new virulence pathways and
drug targets.
Results
A comprehensive PPI network for M. tuberculosis
Based on protein interaction information obtained from
high throughput experiments, we have used a computa-
tional method called homologous protein mapping
(HPM) to predict M. tuberculosis protein interactions at the
proteomic scale. The rationale is that, for any pair of inter-
active proteins validated experimentally in the Database
of Interaction Protein (DIP) [10], two proteins will be pre-
dicted to have a functional linkage if they demonstrate a
higher homology. By this method, interaction evidence
from model organisms was used when orthologs of inter-
acting proteins could be clearly identified in M. tuberculo-
sis. The schematic diagram shown in Fig. 1A is a simplified
model for a protein that corresponds to just one other sin-
gle protein. Using the HPM method, a virtual protein
interaction network of M. tuberculosis H37Rv was con-
structed, consisting of 738 proteins and 5639 non-redun-
dant interaction pairs (see Additional file 1).
Several computational methods have recently been devel-
oped to predict protein interactions [3,11,12]. Bowers and
his co-workers combined these computational algorithms
(A) Schematic diagram of the homologous protein mapping  (HPM) method Figure 1
(A) Schematic diagram of the homologous protein 
mapping (HPM) method. Two proteins are predicted to 
have functional linkage (linked with the yellow line) if they 
have higher homology (linked with the red line) with a pair of 
interactive proteins that have been validated experimentally 
(linked with the blue line). Circles represent different pro-
teins. (B) A local PPI network of hypothetical proteins. 
Thirty-three proteins (green dots) that were annotated as 
hypothetical proteins in genome annotation appeared in the 
predictive protein interaction network generated in this 
study (see Additional file 3).BMC Genomics 2009, 10:118 http://www.biomedcentral.com/1471-2164/10/118
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to predict the protein interaction information for a multi-
tude of microorganisms and released all of these data on
the ProLinks database [13]. To evaluate the reliability of
the PPI network, HPM data were compared with other
computational methods (Table 1). The HPM data had a
relatively high overlap with data produced by the Rosetta
Stone method (RS) [11], although it had a very low over-
lap with that from the Gene Cluster method (GC) [14].
This phenomenon was also observed between other
methods (Table 1), thereby demonstrating that there
might be complementarities between the methods.
In protein interaction networks, the term degree repre-
sents the number of proteins that interact with a given tar-
get protein. The most highly connected proteins are
usually the most important [15] and are considered to
participate extensively in cellular processes. Among the
twenty most highly connected proteins, most were found
to be molecular chaperones, ribosomal proteins and ABC
transporters (see Additional file 2). Molecular chaperones
or ribosomal proteins are especially critical for the organ-
ism because of their extensive functional importance; for
example, molecular chaperones help proteins to fold
exactly and degrade those that fold incorrectly. This is
extremely important for intracellular pathogens especially
when they encounter environmental stresses imposed by
host tissues. It is essential for M. tuberculosis to be able to
resist damage from various pressures exerted by the host
cells, which makes molecular chaperones especially criti-
cal for the survival of M. tuberculosis in its host.
In this respect, it is notable that molecular chaperones of
M. tuberculosis have been reported to differ from those of
other species [16]. For example, M. tuberculosis has two
groEL genes, located in distinct regions of its genome,
while most eubacteria contain only a single copy of this
gene. The protein with the highest degree of connection to
both groEL genes was Rv0685 (Tuf) and this protein
showed increased expression inside macrophages in the
BCG strain [17]. This also implicates molecular chaper-
ones as essential for the survival of M. tuberculosis in its
host, suggesting that these may be potential new drug tar-
gets.
In contrast to what is known regarding molecular chaper-
ones, the functional importance of ABC transporters has
not well been addressed, although these proteins account
for about 2.5% of the genome of M. tuberculosis [18,19].
Their high connections to other network proteins imply
that these transporter proteins might have important, but
as yet unknown, functions in virulence signal transduc-
tion.
Rv2752c is a metallo-beta-lactamase
One important application of the PPI is aid in predicting
the function of proteins forming the network. Thirty-three
proteins have been annotated as hypothetical proteins in
the  M. tuberculosis genome from NCBI; these also
appeared in the PPI networks (Fig. 1B) (also see Addi-
tional file 3). Their contexts within the network provide a
basis by which their potential function and possible roles
in cellular processes can be dissected. For instance,
Rv2752c appeared to be linked to several metal cation-
transporting D-type ATPases, which suggested that it
might also be a metal-related protein (Fig. 2A). Using the
CDD database [20], a metallo-beta-lactamase fold was
found in Rv2752 that contained five sequence motifs. A
lactamase B domain (pfam00753), which is common to
all metallo-beta-lactamase, was found in the first four
motifs of Rv2752 (Fig. 2B). The fifth motif, RMMBL
(pfam07521), existed as a partial metallo-beta-lactamase
and appeared to be specific to the function of the protein.
Therefore, the existence of this RMMBL domain in
Rv2752c implied that it was a typical metallo-beta-lacta-
mase.
Previous research has demonstrated that the expression of
metal-β-lactamases is one of the mechanisms by which
bacterial drug resistances is imparted [21]. For M. tubercu-
losis, the activity of its metallo-beta-lactamase was exam-
ined using the purified protein following expression of
Rv2752c in E. coli. The activity of the metallo-beta-lacta-
mase was detected using a color reaction experiment and
no activity was observed when the enzyme or metal ion
were removed from the reactions (Fig. 2C).
Rv2752c and Rv2897c appeared to share the same context
in local networks (Fig. 2A). Both were linked to several
Table 1: Overlaps between various computational predictive methods.
GC(2625) GN(4351) PP(3894) RS(7533) HPM(6091)
GC(2625) 483 83 148 57
GN(4351) 483 567 323 336
PP(3894) 83 567 690 562
RS(7533) 148 323 690 985
GC, Operon/Gene Cluster method; GN, Conserved Gene methods; PP, Phylogenetic Profile method; RS, Rosetta Stone method; HPM, 
homogenous protein mapping method. HPM datasets was obtained from our work and other datasets obtained from ProLinks database [13]. 
Numbers in small brackets denote interaction pair number in each dataset.BMC Genomics 2009, 10:118 http://www.biomedcentral.com/1471-2164/10/118
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metal cation-transporting D-type ATPases. A Mg-chelatase
domain (pfam01078) was also found in Rv2879c, which
leads us to propose that the Rv2879c gene codes for
another metallo-beta-lactamase.
M. tuberculosis Ser/Thr protein kinases
The completion of the M. tuberculosis genome-sequencing
project has now provided a complete list of 11 eukaryotic-
like Ser/Thr protein kinases that form the M. tuberculosis
STPK family [22]. These protein kinases appear to have
important roles during infection [23,24]. Nine of these
were found in the PPI networks of the current study (Fig.
3).
Ser/Thr protein kinases of M. tuberculosis participate in cell
signaling processes such as cell division [23], fatty acid
metabolism [24] and response to nitric oxide stress [25].
In the current study, two protein kinases, PknK and PknL,
interacted with two cell division proteins, FtsE and FtsH,
respectively, in the PPI network (Fig. 3). In addition, four
network kinases, PknA, PknB, PknJ and PknL, were found
to interact with a group of FadE proteins, indicating a
potential regulatory role in fatty acid metabolism. Addi-
tionally, interactions were found between kinases such as
PknA and PknB, and PknB and PknL, suggesting that co-
regulation may also be occurring in the Ser/Thr protein
kinases signal system.
PknK, although its function has not yet been established,
appeared to extensively interact with the inner mem-
brane-associated ATPase subunits of the network ABC
transporters (Fig. 3). Unlike most protein kinases, PknK
does not have transmembrane domains although it fea-
tures a long regulatory structure in its C-terminus [26]. A
previous study on protein localization showed that PknK
might be associated with the inner membrane [27]. If so,
the PknK may be able to participate in signal transduc-
tions in the nearby inner membrane by interacting with
ABC transporters during infection.
Rv1354c is a potential signal protein associated with ABC 
transporters
Rv1354c is one of thirty-three hypothetical proteins
included in the PPI network (Fig. 1B). Network searching
revealed that Rv1354c interacted with essentially the same
group of ABC transporter ATPase subunits as did PknK
(Fig. 4A). Subcellular localization studies have revealed
that Rv1354c is also associated with the inner membrane
of M. tuberculosis [27]. This is consistent with the fact that
no transmembrane region can be found in the protein
when analyzed by using TMHMM http://www.cbs.dtu.dk/
services/TMHMM/ or SOSUI [28]. Thus, it implies that
Rv1354c may localize near to the inner membrane
through interactions with inner membrane proteins, such
as the ATPase subunits of the ABC transporters. To con-
firm the interactions between Rv1354c and these proteins,
a bacterial two-hybrid assay was conducted. Most of the
contransformants grew well on the screening medium
and no self-activation was observed (Fig. 4B). Therefore,
Rv1354c was apparently interacting with the ABC trans-
porters included in the PPI network (Fig. 4A).
Further domain analysis revealed that Rv1354c contained
two typical domains of GGDEF and EAL (Fig. 5B). Both of
A local PPI network of Rv2752c and its functional assay Figure 2
A local PPI network of Rv2752c and its functional 
assay. (A) A local PPI network of Rv2752c. (B) The domain 
structures of Rv2752c. (C) The activity assay of metallo-beta-
lactamase for Rv2752c. The starch indicator solution and the 
iodine reagent were prepared. A solution containing 10,000 
U of penicillin G per ml of phosphate buffer was freshly pre-
pared and dispensed into small tubes. When a starch indica-
tor was added to the mix with an iodine reagent, a blue color 
immediately developed due to the reaction of the iodine with 
the starch. The 0.6 mL reaction mixture contained 100 mM 
Tris-Cl (pH 7.5), 0.2 M NaCl, 100 ug/mL beta-lactamase, 1 
mg/mL penicillin, 1% (m/v) starch, and I2/KI and with or with-
out 10 mM ZnSO4. The reaction mixture was further rotated 
for up to six minutes at room temperature. Rapid decolori-
zation occurred if the penicillin was hydrolyzed by beta-lacta-
mase, which indicated positive beta-lactamase activity.BMC Genomics 2009, 10:118 http://www.biomedcentral.com/1471-2164/10/118
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these are involved in the turnover of cyclic-di-GMP, a
multi-functional second messenger molecule in bacteria.
The GGDEF domain exhibited diguanylate cyclase (DGC)
activity, which is involved in the synthesis of cyclic-di-
GMP from two GTPs. The EAL domain had the phos-
phodiesterase (PDE) activity required for the hydrolysis of
cyclic-di-GMP [29]. Additionally, a sense domain GAF (E-
value 1e-04) was also found in the N-terminus of
Rv1354c. It has been proposed that the GAF structure has
a role in sensing NO [30], a signal molecule involved in
mediating the antimicrobial activity of macrophages [31].
An Rv1354 homologous protein from the M. smegmatis
has been shown recently to have both in vitro diguanylate
cyclase (DGC) and phosphodiesterase (PDE) activity [32].
Therefore, Rv1354c might be a unique signal protein and
possibly is an essential component of the cyclic-di-GMP
signaling system in M. tuberculosis.
Structure-based inhibitor design for Rv1354c
The cyclic-di-GMP signal system is ubiquitous to bacteria
but is absent in archaea and eukaryotes, making this an
ideal system to target for potential therapeutic drugs. It
also provides a basis for a selective inhibitor design. The
Rv1354c appears to be a unique gene in M. tuberculosis
that contains GAF-GGDEF-EAL domains and interacts
with membrane-associated ABC transporters. Thus,
Rv1354c may play an important role in sensing extracellu-
lar signals and in regulating the transcription of the M.
tuberculosis genes. Additionally, Rv1354c is localized near
to the inner membrane [27], a location that renders it rel-
atively accessible to drugs. Taken together, the data indi-
cate that Rv1354c may be an ideal target for the design of
an anti-tuberculosis drug.
The biochemical and genetic functions of Rv1354c in M.
tuberculosis have not yet been identified experimentally.
For this reason, a structure-based inhibitor screening was
performed, which targeted the GGDEF domain to inhibit
its cyclic-di-GMP synthesis activity. At present, the 3D
structure of Rv1354c is not known. Using the automated
comparative protein modeling web server SWISS-MODEL
[33] and the PleD protein (PDB ID: 2V0N) from Caulo-
bacter vibrioides as a template (Identities = 41%), a struc-
tural modeling of the GGEDF domain of Rv1354c (Fig. 5)
was performed. The 2VON is the structure of the PleD in
complex with cyclic-di-GMP and GTPαS, which provides
critical information for defining the active site. In addi-
tion, a docking-based virtual screening using DOCK6.1
[34] was designed. The Table S4 lists the top 10 hits (see
Additional file 4). This provides the basis for development
of new anti-tuberculosis drugs.
A PPI network of eukaryotic-like Ser/Thr protein kinases Figure 3
A PPI network of eukaryotic-like Ser/Thr protein kinases. The Protein interaction network was visualized using Cyto-
scape [42]. Nodes represent individual proteins and are linked with edges if they interacted with one another. Classes of pro-
teins are colored differently as indicated.BMC Genomics 2009, 10:118 http://www.biomedcentral.com/1471-2164/10/118
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(A) A PPI network of both PknK and Rv1354c with the same group of ABC transporters Figure 4
(A) A PPI network of both PknK and Rv1354c with the same group of ABC transporters. Nodes represent individ-
ual proteins and are linked with edges if they interacted with one another. Classes of proteins are colored differently as indi-
cated. (B) Bacterial analysis of protein-protein interactions. Left panel, plate minus streptomycin (str) and 5 mM 3-amino-1,2,4-
triazole (3-AT). Right panel, plate plus str and 5 mM 3-AT. An outline of the plates represents pairs of cotransformant strains. 
CK+, a cotransformant containing pBT-LGF2 and pTRG-Gal11P as a positive control. CK-, cotransformant containing pBT and 
pTRG as a negative control.BMC Genomics 2009, 10:118 http://www.biomedcentral.com/1471-2164/10/118
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Discussion
M. tuberculosis has been a major killer throughout history.
Currently, it is still responsible for the deaths of about two
million people each year. This unusual pathogenicity sug-
gests that this mycobacterium may use unique mecha-
nisms to facilitate an integrated response to the multiple
stresses encountered upon entry into the phagosome, as
well as for triggering some as-yet-to-be-identified switches
to regulate the different phases of infection. Little is
known regarding the molecular mechanisms of how
extracellular signals may be sensed by M. tuberculosis dur-
ing the infection process. The analysis of the pathogen
interactome is a powerful approach for dissecting poten-
tial virulence pathways in order to explore new drug tar-
gets. In this study, we have described an approach, HPM,
which allows the interactome of M. tuberculosis to be
obtained based on the experimentally verified interac-
tions from DIP (see Additional file 5). We constructed a
comprehensive protein-protein interaction network for
M. tuberculosis, which, upon further analysis, unraveled
the potential function of hypothetical proteins and a
probable signaling pathway. However, these methods,
because they rely on sequence homology, can still give
false positive results. To reduce this risk, we have compre-
hensively evaluated each query protein and its interaction
using the e-value criteria in combination with the cover-
age and the sequence identity of the query to the hit pro-
tein (see Additional file 6).
In recent years, cyclic-di-GMP has been reported as a sec-
ond messenger [29,35,36]. This signal system is involved
in the regulation of a number of complex physiological
processes in numerous pathogenic bacteria, including
biofilm formation and virulence factor production
[29,35,36]. However, the role of this signal system in M.
tuberculosis  is yet to be characterized. In this study, we
found that Rv1354c is a new and unique signal protein
that contains GAF-GGDEF-EAL domains and interacts
with membrane-associated ABC transporters. Given its
characteristics, Rv1354c may play an important role in
sensing extracellular signals and in regulating the tran-
scription of M. tuberculosis genes. This study's analysis
strongly suggests that Rv1354c should be considered an
essential component of the cyclic-di-GMP signaling sys-
tem in M. tuberculosis. Based on the evidence from the cur-
rent study, membrane-associated ABC transporters, a
protein kinase signal, and a cyclic-di-GMP signaling sys-
tem may be coordinating to form an integrated signaling
pathway that allows M. tuberculosis to respond to extracel-
lular stresses.
With the emergence of multi-drug resistant TB and co-
infection with HIV, the incidence of tuberculosis has been
increasing substantially worldwide over the past decade.
However, no tuberculosis-specific drug has been discov-
ered for more than 40 years. Analysis of the pathogen pro-
tein-protein interaction is a powerful approach for
dissecting potential signal transduction and virulence
pathways [37,38]. It also offers opportunities for explor-
ing new drug targets. Two previous studies proposed the
existence of a protein interaction network in M. tuberculo-
sis  based on the subcellular protein profiling [27] and
gene expression profiling [39]. A very recent study dis-
cussed the potential pathways to drug resistance based on
PPI analysis [40]. The current study suggests that the sig-
nal proteins of ABC transporters, PknK and Rv1354c may
have previously unknown functions and probably essen-
tial roles for the in vivo growth of M. tuberculosis. As poten-
tial targets for drug development, these new proteins are
attractive because they are localized near the inner mem-
brane. In particular, the cyclic-di-GMP signaling transduc-
tion protein is apparently absent in human and
mammalian cells and is essential for the virulence and
stress resistance of M. tuberculosis. In this study, we found
for the first time that Rv1354c contains multiple impor-
tant signaling structures including GAF, GGDEF, and EAL
domains, and that it interacts with membrane-associated
ABC transporters. Thus, as a unique cyclic-di-GMP signal-
ing transduction gene in M. tuberculosis, Rv1354c may
play an important role in sensing extracellular signals that
facilitate integrated responses to multiple stresses encoun-
tered by M. tuberculosis within the phagosome. Rv1354c
therefore represents an ideal target for design of an anti-
tuberculosis drug and further research should now focus
(A) Structure-based inhibitor design of Rv1354c Figure 5
(A) Structure-based inhibitor design of Rv1354c. The 
structure of the GGDEF domain was obtained using the 
homology modeling method. The binding conformation of 
the GGDEF domain with GTPαS (red) and ZINC04632254 
(green) from the docking is indicated in a different color 
(More compounds are listed in Additional file 4). (B) Sche-
matic diagram of the Rv1354 domain structure.BMC Genomics 2009, 10:118 http://www.biomedcentral.com/1471-2164/10/118
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on active site and docking-based inhibitors as potential
new chemical weapons against the persistent pathogen M.
tuberculosis.
Conclusion
In this study, we comprehensively analyzed a PPI network
that contained 738 proteins and 5639 non-redundant
interaction pairs. A further analysis of this network
unraveled the function of hypothetical proteins as well as
a potential signaling pathway. A hypothetical protein
Rv2752c was characterized as a metal-beta-lactamase
through a domain analysis and in vitro activity experi-
ment. Rv1354 was proposed to be responsible for the
turnover of cyclic-di-GMP in the bacterium. Its interac-
tions with a group of inner membrane-associated ABC
transporters were confirmed by a bacterial two-hybrid
analysis. Our analysis suggests that the coordination of a
group of ATPase subunits of the ABC transporters, PknK
and Rv1354c constitute a potential membrane-associated
signaling pathway and all represent potential drug targets.
The PPI network developed in this study, coupled with the
findings of potential signal proteins, provides a basis for
understanding the potential virulence and infection
mechanisms of M. tuberculosis. They also suggest areas of
focus in the search for new drug targets.
Methods
Bacterial strains, plasmids, enzymes, primers, and 
chemicals
Escherichia coli BL21 cells, purchased from Novagen, were
used as the host strains to express M. tuberculosis proteins.
The pBT, pTRG vectors and Escherichia coli host strains
were purchased from Stratagene. The pET28a was pur-
chased from Novagen. Restriction enzymes, T4 ligase,
modification enzymes, Pyrobest DNA polymerase, deoxy-
nucleoside triphosphates (dNTPs) and all antibiotics were
obtained from TaKaRa Biotech. All reagents for the two-
hybrid assay were purchased from Stratagene, while all
PCR primers were synthesized by Invitrogen (Table S1).
DNA purification kits were purchased from Watson Bio-
technologies, and the Ni-NTA (Ni2+-nitrilotriacetate) aga-
rose columns were obtained from Qiagen.
Homologous protein mapping
To integrate accumulative protein interaction information
obtained from the high throughput experiment, a compu-
tational method called homologous protein mapping
(HPM) was used to predict M. tuberculosis protein interac-
tions at the proteomic scale. With a pair of interactive pro-
teins validated experimentally in the Database of
Interaction Protein (DIP) [10], two proteins were pre-
dicted to have a functional linkage if they demonstrated
higher homology. The schematic diagram of the HPM
method is a simplified model in which a protein corre-
sponds to just a single protein (Fig. 1A). However, when
the homologous protein is actually defined, one protein
may have a high homology in relation to more than one
protein. In this case, a permutation strategy to create all
possible interaction pairs is then used. For example, given
that A and B have been validated experimentally, if pro-
tein A is homologous to C and D, then protein B is homol-
ogous to E and F. Consequently, the final mapping result
will be composed of interaction pairs of CE, CF, DE and
DF (Fig. 1A).
Construction of a PPI network with HPM
The information collected in DIP as source data were
selected because they integrated many types of evidence
on protein-protein interactions including those from sev-
eral model organisms [10].
The homology of proteins was assigned using the
sequence similarity searching tool, blast [41]. The latest
blast  package (2.2.16) and amino acid sequence of M.
tuberculosis were downloaded from the FTP Web site of
NCBI. Using these amino acid sequence as input, a local
blast database was subsequently constructed using the
program  formatdb  released in the blast  package. The
amino acid sequence of proteins in the DIP database was
downloaded from the DIP Web site (update to
20071007). Subsequently, all of the DIP amino acid
sequence was used in the query. Then, the previous blast
database was employed as target database to perform a
large-scale blast search using blastp (E-value 1e-20). The
preliminary blast results were further processed with our
custom script for a convenient mapping procedure in the
next step. Consequently, the linkage between these two
sets of proteins was procured. Thereafter, the mapping
process was completed according to the strategy described
above. The Protein interaction network was visualized
using Cytoscape [42].
Expression, purification and β-lactamase activity analysis 
of the Rv2752 protein
The vectors expressing mycobacterial protein were con-
structed using the pET28a vector and primers described in
Additional file 7. Escherichia coli BL21 (Novagen) was
used as the host strain to express and purify proteins as
described in a previously published procedures [43]. Puri-
fied proteins were greater than 99% pure as determined by
SDS-PAGE. The beta-lactamase assay was also performed
as previously described [44]. The starch indicator solution
and the iodine reagent were prepared. A solution contain-
ing 10,000 U of penicillin G per ml of phosphate buffer
was freshly prepared and dispensed in small tubes. When
the starch indicator was added to the mix with the iodine
reagent, a blue color immediately developed due to the
reaction of the iodine with the starch. The 0.6 mL reactionBMC Genomics 2009, 10:118 http://www.biomedcentral.com/1471-2164/10/118
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mixture contained 100 mM Tris-Cl (pH 7.5), 0.2 M NaCl,
100 μg/mL beta-lactamase, 1 mg/mL penicillin, 1% (m/v)
starch, and I2/KI and with or without 10 mM ZnSO4. The
reaction mixture was further rotated for up to six minutes
at room temperature. Rapid decolorization occurred if the
penicillin was hydrolyzed by beta-lactamase, which indi-
cated positive beta-lactamase activity.
Bacterial two-hybrid analysis of protein-protein 
interactions
The BacterioMatch II Two-Hybrid System Library Con-
struction Kit (Stratagene) was used to detect protein-pro-
tein interactions between mycobacterial proteins.
Bacterial two-hybrid analysis was carried out according to
the manufacturer's directions. The pBT and pTRG vectors
containing mycobacterial genes were generated. All prim-
ers used for PCR amplification are described in Additional
file 7. Positive growth cotransformants were selected on
the Selective Screening Medium plate containing 5 mM 3-
AT (Stratagene), 8 μg/ml streptomycin, 15 μg/ml tetracy-
cline, 34 μg/ml chloramphenicol, and 50 μg/ml kanamy-
cin. A cotransformant containing pBT-LGF2 and pTRG-
Gal11P (Stratagene) was used as a positive control for
expected growth on the Selective Screening Medium. A
cotransformant containing empty vector pBT and pTRG
was also used as a negative control.
Homology modeling and docking based virtual screening
According to protein interaction information and domain
structures, we propose that Rv1354c is a suitable target for
new anti-tuberculosis drugs, and a docking-based inhibi-
tor screening was performed in silicon. The structure of the
GGDEF domain of Rv1354c was modeled computation-
ally using the automated comparative protein modeling
web server SWISS-MODEL [33]. Likewise, the docking-
based virtual screening was performed using DOCK [34].
The compound library was obtained from the ZINC that
supplied database molecules as 3D formats that were
ready-to-dock [45].
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